Cite
Identification of restrictive molecules involved in oncolytic virotherapy using genome-wide CRISPR screening.
MLA
Zhong, Yiye, et al. “Identification of Restrictive Molecules Involved in Oncolytic Virotherapy Using Genome-Wide CRISPR Screening.” Journal of Hematology & Oncology, vol. 17, no. 1, May 2024, pp. 1–6. EBSCOhost, https://doi.org/10.1186/s13045-024-01554-5.
APA
Zhong, Y., Le, H., Zhang, X., Dai, Y., Guo, F., Ran, X., Hu, G., Xie, Q., Wang, D., & Cai, Y. (2024). Identification of restrictive molecules involved in oncolytic virotherapy using genome-wide CRISPR screening. Journal of Hematology & Oncology, 17(1), 1–6. https://doi.org/10.1186/s13045-024-01554-5
Chicago
Zhong, Yiye, Huangying Le, Xue Zhang, Yao Dai, Fang Guo, Xiaojuan Ran, Guohong Hu, Qi Xie, Dawei Wang, and Yujia Cai. 2024. “Identification of Restrictive Molecules Involved in Oncolytic Virotherapy Using Genome-Wide CRISPR Screening.” Journal of Hematology & Oncology 17 (1): 1–6. doi:10.1186/s13045-024-01554-5.